floxuridine has been researched along with Corridor Disease in 2 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Irvin, AD | 1 |
Stagg, DA | 1 |
Moulton, JE | 1 |
Krauss, HH | 1 |
Malmquist, WA | 1 |
2 other studies available for floxuridine and Corridor Disease
Article | Year |
---|---|
Theileria parva: purine and pyrimidine metabolism and the action of folate antagonists in parasitized bovine lymphoid cells.
Topics: Adenine; Aminopterin; Animals; Azaguanine; Cattle; Cells, Cultured; Culture Media; Eukaryota; Floxur | 1977 |
Growth characteristics of Theileria parva-infected bovine lymphoblast cultures.
Topics: Animals; Cattle; Cell Division; Cells, Cultured; Culture Media; Cytoplasm; Dactinomycin; DNA; Eukary | 1971 |